Delivery Order SPE2DX22D0049-SPE2D826FA2GA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,793.06 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by December 9, 2025. The delivery order represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,854.23 by the Medical Supply Chain, a defense-focused federal agency, on November 17, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside provisions, is scheduled for completion by November 18, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,572.48 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025. This firm fixed price delivery order, with an ultimate completion date of December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,936.04 by the Defense Logistics Agency's Medical Supply Chain on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,080.31 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025. This firm fixed-price delivery order, which is set to be completed by December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,500.08 on November 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a completion date of November 7, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract award valued at $7,983.12 from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. This firm fixed-price delivery order, with a completion date of September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,872.20 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside provisions, is scheduled for ultimate completion on August 29, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA2GADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,838.53 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 9, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for the company's global pharmaceutical support to military healthcare programs. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical and medical supply provision to federal defense and healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company maintains an extensive portfolio of pharmaceutical deliveries spanning multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The award reflects the company's demonstrated capability to meet federal procurement requirements through open competition and its critical role in supporting military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 12/7/25 |